![ONDETAS-DROP](data:image/svg+xml,%3Csvg xmlns="http://www.w3.org/2000/svg" width="800" height="800" viewBox="0 0 24 24" fill="none" stroke="%239CA3AF" stroke-width="1.5"%3E%3Cpath stroke-linecap="round" stroke-linejoin="round" d="M19 11H5m14 0a2 2 0 012 2v6a2 2 0 01-2 2H5a2 2 0 01-2-2v-6a2 2 0 012-2m14 0V9a2 2 0 00-2-2M5 11V9a2 2 0 012-2m0 0V5a2 2 0 012-2h6a2 2 0 012 2v2M7 7h10"/%3E%3C/svg%3E)
Antiemetics
ONDETAS-DROP
SALT COMPOSITION
ONDANSETRON HCL 2MG /5MLTYPE
DROP
STORAGE
Store ONDETAS-DROP below 30°C in a cool, dry place. Protect from direct sunlight and moisture. Do not freeze. Keep the bottle tightly closed when not in use and out of reach of children.
PRODUCT INTRODUCTION
ONDETAS-DROP, containing Ondansetron HCL 2MG /5ML, is a highly effective antiemetic medication designed to prevent and treat nausea and vomiting. This pediatric-friendly drop formulation is ideal for infants and children, ensuring precise dosing and ease of administration. Widely prescribed in India, ONDETAS-DROP works by blocking specific chemicals in the brain that trigger feelings of sickness, providing much-needed relief. It is commonly used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery, making it a trusted choice for healthcare professionals and parents alike. Always consult a doctor for appropriate dosage and usage.
Uses of ONDETAS-DROP
ONDETAS-DROP is primarily used to prevent and treat nausea and vomiting caused by various medical conditions and treatments. It is particularly effective in pediatric patients.
- Chemotherapy-Induced Nausea and Vomiting (CINV)
ONDETAS-DROP is highly effective in preventing and treating severe nausea and vomiting that often accompanies cancer chemotherapy. Chemotherapeutic agents can release serotonin in the gut, triggering the vomiting reflex. Ondansetron blocks these signals, providing significant relief and improving the quality of life for pediatric patients undergoing cancer treatment. Proper dosing as prescribed by a pediatrician is crucial for optimal outcomes.
- Radiotherapy-Induced Nausea and Vomiting (RINV)
Patients, especially children, undergoing radiation therapy to the abdomen or total body irradiation frequently experience nausea and vomiting. ONDETAS-DROP helps to alleviate these distressing symptoms by targeting the serotonin pathways activated by radiation. This allows children to better tolerate their treatment sessions and maintain their nutritional intake, contributing to a smoother recovery process. Adherence to prescribed dosage is important.
- Post-Operative Nausea and Vomiting (PONV)
Nausea and vomiting are common side effects after surgical procedures, particularly in children. ONDETAS-DROP is indicated for the prevention and treatment of PONV. By administering it before or after surgery as directed by a healthcare professional, it significantly reduces the incidence and severity of these symptoms, leading to a more comfortable and faster recovery for pediatric patients. Always follow the doctor's instructions meticulously.
Side Effects of ONDETAS-DROP
Like all medicines, ONDETAS-DROP can cause side effects, although not everybody gets them. Most side effects are mild and temporary. If any of these side effects bother you or persist, please consult your doctor.
Common side effects
- Headache
- Constipation
- Diarrhea
- Fatigue
- Dizziness
Less common or rare side effects may occur. Seek immediate medical attention if you experience any of the following serious reactions:
- Allergic reactions (rash, itching, swelling, severe dizziness, trouble breathing)
- Chest pain or irregular heartbeat (QT prolongation)
- Vision disturbances (temporary blindness)
If you notice any other side effects not listed here, or if any side effect gets serious, please tell your doctor or pharmacist. Do not discontinue the medication without consulting your healthcare provider.
How to use ONDETAS-DROP
- Adults:
While ONDETAS-DROP is primarily for pediatric use, for adult indications requiring this concentration, the typical dose for preventing chemotherapy-induced nausea and vomiting (CINV) is 8 mg (equivalent to 20 ml of ONDETAS-DROP) administered 30 minutes before chemotherapy, followed by 8 mg every 8-12 hours for 1-2 days. For post-operative nausea and vomiting (PONV), 4 mg (10 ml) may be given prior to anesthesia or post-operatively. Always follow your doctor's specific instructions.
- Children:
For children, the dosage of ONDETAS-DROP is determined by body weight or surface area and the specific indication. For CINV, typically 0.15 mg/kg per dose, given 30 minutes before chemotherapy, repeated 4 and 8 hours after the first dose. For PONV, a single dose of 0.1 mg/kg (up to 4 mg) can be given before or after surgery. Administer using the provided dropper for accurate measurement. Do not exceed the prescribed dose. Consult a pediatrician for precise dosing instructions.
- Elderly:
No specific dosage adjustment is generally required for elderly patients with normal renal and hepatic function. However, due to the potential for age-related decline in organ function and increased sensitivity to medications, a cautious approach is recommended. Your doctor may start with a lower dose and monitor for side effects. Always inform your doctor about all current medications and health conditions.
- Missed Dose:
If you miss a dose of ONDETAS-DROP, administer it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up. Consistent dosing is important for effective control of nausea and vomiting, especially during ongoing treatments like chemotherapy. Consult your doctor if you are unsure.
How ONDETAS-DROP works
Ondansetron, the active ingredient in ONDETAS-DROP, is a selective serotonin 5-HT3 receptor antagonist. Nausea and vomiting are often mediated by the release of serotonin (5-HT) from enterochromaffin cells in the gastrointestinal mucosa, which then stimulates 5-HT3 receptors on vagal afferent nerves, transmitting signals to the chemoreceptor trigger zone (CTZ) in the brain. The CTZ, in turn, activates the vomiting center, leading to emesis. ONDETAS-DROP works by blocking these 5-HT3 receptors, both peripherally on vagal nerve terminals and centrally in the CTZ. By inhibiting the binding of serotonin to these receptors, Ondansetron effectively prevents the initiation of the vomiting reflex. This dual action ensures comprehensive control over various forms of nausea and vomiting, offering significant relief to patients, especially children undergoing treatments like chemotherapy or surgery.
Precautions
- Inform your doctor if you have a history of heart problems, including irregular heartbeats (arrhythmias) or prolonged QT interval.
- Exercise caution if you have liver impairment, as dosage adjustments may be necessary.
- Patients with electrolyte imbalances (e.g., low potassium or magnesium) should be monitored.
- Avoid use in patients with a known hypersensitivity to ondansetron or any of its components.
- Report any signs of an allergic reaction, such as rash, itching, or swelling, immediately.
- Inform your doctor about all other medications, including herbal supplements, to avoid potential drug interactions.
Safety Advice
Alcohol
CAUTIONIt is advisable to limit or avoid alcohol consumption while taking ONDETAS-DROP. Alcohol can exacerbate dizziness and drowsiness, which are potential side effects of Ondansetron, thereby increasing the risk of impaired coordination.
Pregnancy
CONSULT YOUR DOCTORONDETAS-DROP should be used during pregnancy only if clearly needed and after careful consideration by a doctor. While studies have not shown clear evidence of harm, it's crucial to discuss the potential risks and benefits with your healthcare provider before use.
Breastfeeding
CONSULT YOUR DOCTOROndansetron is known to pass into breast milk in small amounts. Therefore, it is recommended to consult your doctor before using ONDETAS-DROP while breastfeeding. Your doctor will weigh the benefits of treatment against any potential risks to the infant.
Driving
CAUTIONONDETAS-DROP can cause dizziness or drowsiness in some individuals. If you or your child experience these side effects, it is advisable to avoid driving or operating heavy machinery. Ensure alertness before engaging in activities requiring concentration.
Kidney
SAFE IF PRESCRIBEDONDETAS-DROP is generally considered safe for use in patients with kidney disease, and no dosage adjustment is typically required. However, if you have severe kidney impairment, it is always best to consult your doctor for personalized advice and monitoring.
Liver
CONSULT YOUR DOCTORPatients with moderate to severe liver disease may require a reduced dose of ONDETAS-DROP, as the medication is primarily metabolized by the liver. It is crucial to inform your doctor about any liver conditions so they can adjust the dosage accordingly and monitor your liver function.
Fact Box
Frequently asked questions by patients
Q: How quickly does ONDETAS-DROP start working?
A: ONDETAS-DROP typically starts to show its effects within 30 minutes to an hour after administration. The rapid onset of action helps in providing quick relief from nausea and vomiting, especially important for children undergoing treatments that cause these symptoms.
Q: Can ONDETAS-DROP be given with food?
A: ONDETAS-DROP can be administered with or without food. However, for better tolerance and to minimize any potential stomach upset, some individuals might prefer taking it after a meal. Always follow your doctor's specific instructions regarding administration.
Q: What if my child vomits immediately after taking ONDETAS-DROP?
A: If your child vomits within one hour of taking ONDETAS-DROP, it is generally recommended to give another dose. However, if it's been more than an hour, do not give an extra dose. Consult your pediatrician for specific guidance in such situations.
Q: Is ONDETAS-DROP safe for long-term use?
A: ONDETAS-DROP is generally prescribed for short-term use, especially around chemotherapy, radiation, or surgery. Long-term use should only be considered under strict medical supervision, as prolonged use might lead to certain side effects. Always adhere to your doctor's prescribed duration.
Frequently Asked Questions
Q: What is ONDETAS-DROP used for?
ONDETAS-DROP is an antiemetic medication primarily used to prevent and treat nausea and vomiting. It is particularly effective for managing these symptoms caused by cancer chemotherapy, radiation therapy, and surgical procedures in pediatric patients. Its active ingredient, Ondansetron, helps block the signals that trigger the vomiting reflex.
Q: How should ONDETAS-DROP be administered to children?
ONDETAS-DROP should be administered orally using the provided dropper for accurate measurement. The dosage for children is determined by their body weight or surface area and the specific condition being treated. Always follow the precise dosing instructions given by your pediatrician and do not exceed the recommended dose.
Q: Are there any serious side effects of ONDETAS-DROP?
While ONDETAS-DROP is generally well-tolerated, some serious side effects, though rare, can occur. These include severe allergic reactions (rash, swelling, difficulty breathing), chest pain, irregular heartbeat (QT prolongation), or temporary vision disturbances. Seek immediate medical attention if you notice any of these serious symptoms.
Q: Can ONDETAS-DROP be given with other medications?
It is crucial to inform your doctor about all other medications, including over-the-counter drugs, vitamins, and herbal supplements, that your child is currently taking. Ondansetron can interact with certain medications, such as tramadol, apomorphine, or other drugs that affect heart rhythm, potentially leading to adverse effects. Your doctor will assess for potential interactions.
Q: What precautions should be taken while using ONDETAS-DROP?
Before administering ONDETAS-DROP, inform your doctor if your child has any heart conditions, liver problems, or electrolyte imbalances. Also, report any history of allergic reactions to similar medications. Close monitoring is advised, especially in patients with pre-existing medical conditions, to ensure safe and effective use of the medication.
Additional Information
ONDETAS-DROP, with its active ingredient Ondansetron HCL 2MG /5ML, stands as a reliable and effective solution for managing nausea and vomiting, particularly in the pediatric population. Its convenient drop formulation ensures accurate dosing and ease of administration, making it a preferred choice for parents and healthcare providers in India. By targeting the specific serotonin receptors responsible for triggering emesis, ONDETAS-DROP provides rapid and significant relief from symptoms associated with chemotherapy, radiation therapy, and post-operative recovery. While generally well-tolerated, it is essential to adhere strictly to the prescribed dosage and administration guidelines provided by a qualified healthcare professional. Awareness of potential side effects and necessary precautions, especially concerning pre-existing conditions like heart or liver issues, is crucial for safe usage. ONDETAS-DROP plays a vital role in improving the comfort and quality of life for children undergoing challenging medical treatments, helping them to better tolerate therapy and recover more smoothly. Always consult your doctor for personalized medical advice and treatment plans.